Results 221 to 230 of about 357,788 (307)

Nephrology [PDF]

open access: yesArchives of Disease in Childhood, 2000
openaire   +1 more source

Trends and Racial/Ethnic Disparities in Pharmacologic and Surgical Management of Treated Female Patients With Urinary Incontinence

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Background The current literature summarizes the trends in the surgical management of stress urinary incontinence (SUI) and not the general trends of management for all UI types in the US. Additionally, recent evidence on racial and ethnic disparities in UI related surgical utilization is limited. Objective To describe the currently prescribed
Rawan O. Almadfaa   +5 more
wiley   +1 more source

Roxadustat for Erythropoiesis-Stimulating Agent Hyporesponsive Anemia in Hemodialysis: Multicenter Retrospective Analysis. [PDF]

open access: yesMedicina (Kaunas)
Ozturk I   +11 more
europepmc   +1 more source

Urinary Incontinence and Risk of All‐Cause Mortality: A Systematic Review and Meta‐Analysis of Observational Studies

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims Urinary incontinence (UI) is a prevalent condition among adults and imposes a substantial societal burden, yet its association with all‐cause mortality remains uncertain. This study systematically reviewed and quantified the association between UI and mortality risk.
Yanyan Zhou   +6 more
wiley   +1 more source

The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD. [PDF]

open access: yesKidney Int Rep
Paolisi M   +8 more
europepmc   +1 more source

Symptom Relief and Practice Setting Variation in Bulkamid Injections for Stress Urinary Incontinence

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Bulkamid™ transurethral injection is a minimally invasive treatment for stress urinary incontinence (SUI) and mixed urinary incontinence (MUI). While effective, predictors of repeat injection, progression to sling, and the influence of anesthesia type on treatment efficacy remain incompletely defined.
Christina Sze   +6 more
wiley   +1 more source

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy